These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3805663)

  • 1. Quantification of disease activity in patients with ulcerative colitis.
    Kambe H; Yoshida T; Haraguchi Y; Iwashita T; Sakamoto A; Tanaka K
    J Clin Gastroenterol; 1986 Dec; 8(6):651-4. PubMed ID: 3805663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An index of disease activity in patients with ulcerative colitis.
    Seo M; Okada M; Yao T; Ueki M; Arima S; Okumura M
    Am J Gastroenterol; 1992 Aug; 87(8):971-6. PubMed ID: 1642220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and laboratory indicators of extent of ulcerative colitis. Serum C-reactive protein helps the most.
    Prantera C; Davoli M; Lorenzetti R; Pallone F; Marcheggiano A; Iannoni C; Mariotti S
    J Clin Gastroenterol; 1988 Feb; 10(1):41-5. PubMed ID: 3356884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of serologic markers as a screening tool in inflammatory bowel disease compared with elevated erythrocyte sedimentation rate and anemia.
    Sabery N; Bass D
    Pediatrics; 2007 Jan; 119(1):e193-9. PubMed ID: 17158948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Method of diagnosis of the severity of the disease attack in patients with ulcerative colitis.].
    Tretyakova YI; Bulatova IA; Shchekotova AP; Sheludko VS
    Klin Lab Diagn; 2018; 63(7):414-418. PubMed ID: 30720956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum eosinophil cationic protein in active and quiescent ulcerative colitis.
    Pronk-Admiraal CJ; Linskens RK; Van Bodegraven AA; Tuynman HA; Bartels PC
    Clin Chem Lab Med; 2000 Jul; 38(7):619-22. PubMed ID: 11028767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of inflammatory and coagulation parameters in the course of severe ulcerative colitis.
    Linskens RK; van Bodegraven AA; Schoorl M; Tuynman HA; Bartels P
    Dig Dis Sci; 2001 Mar; 46(3):644-8. PubMed ID: 11318546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biopsy pathology predicts patients with ulcerative colitis subsequently requiring surgery.
    Tanaka M; Saito H; Kusumi T; Shimoyama T; Fukuda S; Morita T; Sugita A; Hara M; Kudo H
    Scand J Gastroenterol; 2002 Feb; 37(2):200-5. PubMed ID: 11843058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis.
    Minami T; Tojo H; Shinomura Y; Tarui S; Okamoto M
    Gut; 1992 Jul; 33(7):914-21. PubMed ID: 1644331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe eosinophilic infiltration in colonic biopsies predicts patients with ulcerative colitis not responding to medical therapy.
    Zezos P; Patsiaoura K; Nakos A; Mpoumponaris A; Vassiliadis T; Giouleme O; Pitiakoudis M; Kouklakis G; Evgenidis N
    Colorectal Dis; 2014 Dec; 16(12):O420-30. PubMed ID: 25040651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic imbalance in active and quiescent ulcerative colitis.
    van Bodegraven AA; Schoorl M; Baak JP; Linskens RK; Bartels PC; Tuynman HA
    Am J Gastroenterol; 2001 Feb; 96(2):487-93. PubMed ID: 11232695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors of glucocorticosteroid treatment failure in severe acute idiopathic colitis.
    Elloumi H; Ben Abdelaziz A; Derbel F; Jmaa A; Lassoued Y; Arfaoui D; Ben Ali A; Letaief R; Hamida RB; Ghannem H; Ajmi S
    Acta Gastroenterol Belg; 2005; 68(2):226-9. PubMed ID: 16013638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis.
    Wine E; Mack DR; Hyams J; Otley AR; Markowitz J; Crandall WV; Leleiko N; Muise AM; Griffiths AM; Turner D
    J Crohns Colitis; 2013 Dec; 7(11):916-22. PubMed ID: 23339932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated markers of thrombin generation and fibrinolysis in patients with active and quiescent ulcerative colitis.
    Zezos P; Papaioannou G; Nikolaidis N; Patsiaoura K; Vassiliadis T; Mpoumponaris A; Giouleme O; Evgenidis N
    Med Sci Monit; 2009 Nov; 15(11):CR563-72. PubMed ID: 19865055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis.
    Osada T; Ohkusa T; Okayasu I; Yoshida T; Hirai S; Beppu K; Shibuya T; Sakamoto N; Kobayashi O; Nagahara A; Terai T; Watanabe S
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S262-7. PubMed ID: 19120909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposal of a new clinical index predictive of endoscopic severity in ulcerative colitis.
    Azzolini F; Pagnini C; Camellini L; Scarcelli A; Merighi A; Primerano AM; Bertani A; Antonioli A; Manenti F; Rigo GP
    Dig Dis Sci; 2005 Feb; 50(2):246-51. PubMed ID: 15745080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and mucosal prostaglandin E2 as a surrogate marker of ulcerative colitis activity.
    Wiercińska-Drapało A; Flisiak R; Prokopowicz D
    Rocz Akad Med Bialymst; 2001; 46():60-8. PubMed ID: 11780581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma viscosity in inflammatory bowel disease.
    Lobo AJ; Jones SC; Juby LD; Axon AT
    J Clin Pathol; 1992 Jan; 45(1):54-7. PubMed ID: 1740516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C; Wiebecke B; Loeschke K
    Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.